Agroterrorism and Agro Crime to United States Cannabis Industry. Discusses agrothreats from crime to terrorism to the US Cannabis Industry. Offers solutions to legislation to ensure cannabis is safe.
The document discusses the issue of counterfeit prescription drugs, particularly those imported from other countries. It notes that while the FDA's drug distribution system in the US is considered the safest in the world, the number of counterfeit drug cases has risen in recent years. The FDA ordered drugs from a website claiming to offer cheaper generics from Canada, but testing showed the drugs actually came from China and were either too strong or weak, or contained dangerous impurities. Importing drugs from other countries is not safe and raises legal and health issues.
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...OECD Governance
Presentation made by Kristina M. Lybecker, The Colorado College at the 3rd meeting of the OECD Task Force on Charting Illicit Trade - OECD, Paris, 30-31 March 2015
For more information see http://www.oecd.org/gov/risk/charting-illicit-trade-third-task-force-meeting.htm
The document discusses the dangers American patients face from counterfeit medications obtained outside of the regulated US drug supply chain, such as through fake online Canadian pharmacies. It details how breaks in the secure supply chain, such as patients buying drugs online or some doctors and pharmacists obtaining drugs from unlicensed distributors, can endanger patients by exposing them to counterfeit and unsafe medications. The document aims to dispel myths about obtaining cheaper drugs from outside the US and provides tips for patients to stay safe.
Counterfeit drugs pose a major global problem and public health risk. According to the World Health Organization, over half of counterfeit drug cases found no active ingredients, while others contained incorrect or dangerous ingredients. Developing countries are especially impacted, with up to 60% of reported counterfeit drugs. Counterfeiting undermines healthcare systems and can have deadly consequences. The document warns that weak drug regulation and an unsecured supply chain allow for counterfeits to proliferate. It advocates purchasing from authorized drug distributors only to help strengthen oversight of the pharmaceutical supply system.
Counterfeit drugs: what a doctor should knowMark Davison
Short lecture to medical students on risks, prevalence and detection of fake medicines and protection of patient safety. Essential training for new doctors and pharmacists.
Healthcare providers are increasingly breaking the secure supply chain and endangering patients. Learn about counterfeit drugs and most recent incidents involving providers.
Also learn about how you can be a part of the solution by working with the Partnership for Safe Medicines.
Counterfeit medicines are drugs produced with the intention to deceive that contain incorrect or insufficient active ingredients which can lead to therapeutic failure or drug resistance and sometimes death. Substandard medicines are genuine drugs that do not meet quality specifications due to manufacturing problems and may contain less or more active ingredients than stated. The most frequently counterfeited drugs are expensive medicines like hormones, antibiotics, and anticancer drugs. Globally, 10% of drugs are counterfeit, rising to 25% in developing countries and 50% in some places. Counterfeiting is encouraged by the profitability, weak laws, and large price differences between identical drugs. Actions to address the problems include strong legislation, authentication markings on packages, surveillance, and education.
The document discusses the issue of counterfeit prescription drugs, particularly those imported from other countries. It notes that while the FDA's drug distribution system in the US is considered the safest in the world, the number of counterfeit drug cases has risen in recent years. The FDA ordered drugs from a website claiming to offer cheaper generics from Canada, but testing showed the drugs actually came from China and were either too strong or weak, or contained dangerous impurities. Importing drugs from other countries is not safe and raises legal and health issues.
Illicit Trade in Counterfeit Medicine by Kristina M. Lybecker, The Colorado C...OECD Governance
Presentation made by Kristina M. Lybecker, The Colorado College at the 3rd meeting of the OECD Task Force on Charting Illicit Trade - OECD, Paris, 30-31 March 2015
For more information see http://www.oecd.org/gov/risk/charting-illicit-trade-third-task-force-meeting.htm
The document discusses the dangers American patients face from counterfeit medications obtained outside of the regulated US drug supply chain, such as through fake online Canadian pharmacies. It details how breaks in the secure supply chain, such as patients buying drugs online or some doctors and pharmacists obtaining drugs from unlicensed distributors, can endanger patients by exposing them to counterfeit and unsafe medications. The document aims to dispel myths about obtaining cheaper drugs from outside the US and provides tips for patients to stay safe.
Counterfeit drugs pose a major global problem and public health risk. According to the World Health Organization, over half of counterfeit drug cases found no active ingredients, while others contained incorrect or dangerous ingredients. Developing countries are especially impacted, with up to 60% of reported counterfeit drugs. Counterfeiting undermines healthcare systems and can have deadly consequences. The document warns that weak drug regulation and an unsecured supply chain allow for counterfeits to proliferate. It advocates purchasing from authorized drug distributors only to help strengthen oversight of the pharmaceutical supply system.
Counterfeit drugs: what a doctor should knowMark Davison
Short lecture to medical students on risks, prevalence and detection of fake medicines and protection of patient safety. Essential training for new doctors and pharmacists.
Healthcare providers are increasingly breaking the secure supply chain and endangering patients. Learn about counterfeit drugs and most recent incidents involving providers.
Also learn about how you can be a part of the solution by working with the Partnership for Safe Medicines.
Counterfeit medicines are drugs produced with the intention to deceive that contain incorrect or insufficient active ingredients which can lead to therapeutic failure or drug resistance and sometimes death. Substandard medicines are genuine drugs that do not meet quality specifications due to manufacturing problems and may contain less or more active ingredients than stated. The most frequently counterfeited drugs are expensive medicines like hormones, antibiotics, and anticancer drugs. Globally, 10% of drugs are counterfeit, rising to 25% in developing countries and 50% in some places. Counterfeiting is encouraged by the profitability, weak laws, and large price differences between identical drugs. Actions to address the problems include strong legislation, authentication markings on packages, surveillance, and education.
The document provides information on counterfeit drugs, including definitions, global and Indian statistics, examples of counterfeited drugs, and potential solutions. Some key points:
- The WHO defines counterfeit drugs as deliberately mislabeled regarding identity and/or source, and they may contain incorrect ingredients, insufficient active ingredients, or no active ingredients.
- India accounts for 10% of global drug production but also has high rates of counterfeiting, estimated at 20% of drugs. Globally, counterfeiting costs the legitimate pharmaceutical industry $75 billion annually.
- Many popular drugs are frequently counterfeited, such as Viagra, Lipitor, and cancer treatments. Counterfeits are found to contain
In this presentation, Director of National Outreach Shabbir Imber Safdar reviews the current state of counterfeit drugs in America today, discusses some of the myths surrounding importation, and provides tips for saving money safely on the cost of prescription drugs.
The document discusses counterfeit medicine, including its definition, prevalence, consequences, evaluation, and methods to prevent it. It states that counterfeit medicine ranges from having no active ingredients to incorrect ingredients, and affects both developing and developed countries. Evaluation methods include using RFID, barcodes, Raman spectroscopy, and forensic analysis to identify counterfeits. Legislative authorities and improved regulation aim to curb the estimated $90 billion global counterfeit drug industry that causes over 1 million deaths annually.
1. Counterfeit drugs are a major global problem that negatively impact public health and pharmaceutical companies. They range from lacking active ingredients to having incorrect dosages and can lead to treatment failure, increased antimicrobial resistance, and even death.
2. India accounts for a large portion of the global counterfeit drug trade due to its large pharmaceutical industry, lack of regulation, and high drug prices. Many counterfeit drugs originate in India and are distributed worldwide.
3. Strategies to reduce counterfeiting include strengthening drug regulation, increasing inspections, consumer awareness campaigns, implementing track-and-trace technologies like barcodes and RFID in supply chains, and harsher penalties for counterfeiters.
The document discusses counterfeit medicines, which the WHO defines as deliberately mislabeled drugs regarding identity and/or source. Counterfeits can include both branded and generic drugs with incorrect ingredients, dosages, or packaging. Medicines are targeted due to lax regulations in some countries, price differences globally, and the complexity of distribution systems. Counterfeits pose health risks as they provide ineffective treatment and can spread drug-resistant diseases. Stronger enforcement is needed across governments, industries, and distribution networks to prioritize combating counterfeit drugs.
Securing the Global Pharmaceutical Supply Chain against the Threat of Counter...Yasmin AbdelAziz
In 2012, counterfeit versions of the cancer drug
Avastin were found in 19 American treatment
centers. The impostor drug lacked the active
ingredient, rendering it virtually useless for
treatment purposes.
I have been working on the topic of anti-counterfeiting for a number of years and find myself increasingly engrossed and thoroughly surprised as our understanding of this topic grows. The imagination and the brutality with which the criminal industry produces, distributes and sells imitation goods is unmatched. The consequences of such dire acts are not only killing children but also affecting the lives of many and fighting such forgery has become a personal battle for me.
This document discusses counterfeit medicines and measures to combat them. It defines counterfeit medicines according to WHO as those deliberately mislabeled regarding identity and/or source. The most common types of counterfeits are those without active ingredients or with incorrect quantities. Counterfeiting is prevalent in developing countries and online pharmacies. It poses dangers like treatment failure, toxicity, and drug resistance. Detection methods include chemical kits, barcodes, and Raman spectroscopy. Measures to combat counterfeits involve legislation, regulation, international cooperation, and awareness campaigns. Pharmacists play a role in preventing counterfeits from entering the supply chain.
In this webinar I provide an overview of counterfeits in America, I talk about some myths of importation, and I teach patients and patient advocates some great tips for saving money safely.
Online Access to Safe and Affordable Medication: Applying human rights law to...PharmacyChecker
Online Access to Safe and Affordable Medication: Applying human rights law to cyber rule-making and Internet governance
https://www.pharmacychecker.com/
Internet users are benefiting from online access to safe and affordable medications. The pharmaceutical industry views Internet access as a threat and disruptive to its profit model because consumers are paying less than the drug companies intended for them to pay. According to the UN Human Rights Council, access to affordable medication is a human right. As the Internet community seeks to infuse the principles of international human rights law into the discourse and practice of Internet governance it should help maintain the widest possible online access to safe and affordable medication.
https://www.pharmacychecker.com/
This document discusses the importance of proper labeling and promotion of drugs, as well as the various legal risks associated with mislabeling or improper promotion. It notes that manufacturers have the most information about drugs from clinical trials and post-market reports. The document defines what constitutes a drug label and outlines labeling requirements for both prescription and over-the-counter drugs. It also discusses standards and regulations from the FDA, FTC, and tort law regarding labeling as well as restrictions and exceptions for drug advertising and promotion.
This document discusses how cost considerations are driving the adoption of lean technologies in biosimilar manufacturing. Biosimilars face price pressure to compete with originator biologics, whose manufacturing processes are 10-15 years old. Newer technologies like single-use systems, perfusion bioreactors, and analytics like Biacore allow biosimilar manufacturers to develop smaller, more efficient continuous processes compared to legacy facilities. These lean technologies may help biosimilars achieve the cost competitiveness needed in the market.
This document summarizes the history of drug laws in the United States from the 1700s to present day. It discusses early regulation of alcohol and opium, the 1906 Pure Food and Drug Act, the Harrison Narcotic Act of 1914, prohibition, the Marihuana Tax Act of 1937, and major drug laws passed in the 1960s-2000s that aimed to increase drug safety regulations, control narcotics, and enforce harsher penalties for drug offenses. It also explores debates around decriminalization, legalization, harm reduction strategies, and the impacts of the war on drugs.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
This presentation is designed to train patient advocates in the safety issues around counterfeit drugs: how counterfeits enter our supply chain and how patients can protect themselves.
http://profitabletradingtips.com/trading-investing/trading-marijuana-stocks
Trading Marijuana Stocks
The state of Colorado has legalized marijuana for recreational use. Is there money to be made trading marijuana stocks? Technical analysis of these stocks may be difficult because of small trading volume. But, if other states adopt similar laws, trading marijuana stocks could be profitable to get in before stocks surge and get out before they level off. So, before we look at trading marijuana stocks let us look at the law in Colorado.
Colorado Law Regarding Marijuana Use
Colorado has two sets of laws regarding marijuana. These have to do with recreational use and medical use.
Colorado Amendment 64 says that:
adults aged twenty-one or older can grow up to three immature and three mature cannabis plants privately in a locked space, legally possess all cannabis from the plants they grow (as long as it stays where it was grown), legally possess up to one ounce of cannabis while traveling, and give as a gift up to one ounce to other citizens 21 years of age or older. Consumption is permitted in a manner similar to alcohol, with equivalent offenses proscribed for driving. Public consumption remains illegal. Amendment 64 also provides for licensing of cultivation facilities, product manufacturing facilities, testing facilities, and retail stores.
This law allows for sales of marijuana for recreational use, taxation of profits from these facilities, and various ordinances relating to such establishments. It is the potential for profit from recreational use of marijuana that is of primary interest in trading marijuana stocks.
Todays Marijuana And Its Effects on KidsSmartColorado
This document discusses the effects of legalized marijuana in Colorado, particularly on youth. It notes that while Amendment 64 legalized possession of small amounts of marijuana for adults 21+, commercialization of the drug has increased availability and lowered perceptions of risk among youth. Early and regular marijuana use can negatively impact adolescent brain development and is linked to higher risks of addiction, mental health issues, and lower IQ. The document expresses concerns about how the largely unregulated marijuana industry may be modeling practices after Big Tobacco to target and influence youth.
What Growers & Investors Need to Know: The cultivation laws in Oregon, Washington, Colorado and California are vastly different. Eric explains each states current cultivation laws and the reasons behind them. In addition to the best management practices for growing cannabis in a greenhouse environment for each states climate.
This document discusses medical marijuana. It provides background on marijuana and its classification. It assesses the efficacy and safety of medical marijuana for conditions like nausea, pain, appetite stimulation, and others. It also explains the legal implications of medical marijuana in the US and in states like Colorado and Illinois that have legalized it. Remaining challenges include a lack of standardized dosing and quality control. The pharmacist's role could include counseling patients, assessing drug interactions, and producing customized dosage forms.
Marijuana: The #1 Profit Opportunity for Greenhouse Growers in the Next DecadeGGS Structures Inc.
The document discusses the potential opportunities for greenhouse growers in the cannabis industry over the next decade. It notes that the legal cannabis market in the US and Canada is projected to be worth $44 billion by 2020. It provides an overview of the medical cannabis programs in Canada and regulations for licensed producers. The document also discusses factors for greenhouse growers to consider such as ventilation, lighting, irrigation and computer controls if pursuing cannabis cultivation. It emphasizes doing research and evaluating what skills align with long-term goals before deciding to enter the emerging industry.
Starting a Colorado Dispensary – Permits and Licenses You Should HaveDashThomas
To open a dispensary in Colorado, you will need several permits and licenses. Specifically, you need a medical marijuana vendor registration, seller's permit, Colorado medical marijuana business license, and either a key employee or support employee occupational license. You may also require a medical marijuana center business license, optional premises cultivation license, or infused product manufacturer license depending on the services offered. The Dispensary Experts website provides guidance on obtaining the necessary permits and licenses to legally operate a dispensary in Colorado.
The document provides information on counterfeit drugs, including definitions, global and Indian statistics, examples of counterfeited drugs, and potential solutions. Some key points:
- The WHO defines counterfeit drugs as deliberately mislabeled regarding identity and/or source, and they may contain incorrect ingredients, insufficient active ingredients, or no active ingredients.
- India accounts for 10% of global drug production but also has high rates of counterfeiting, estimated at 20% of drugs. Globally, counterfeiting costs the legitimate pharmaceutical industry $75 billion annually.
- Many popular drugs are frequently counterfeited, such as Viagra, Lipitor, and cancer treatments. Counterfeits are found to contain
In this presentation, Director of National Outreach Shabbir Imber Safdar reviews the current state of counterfeit drugs in America today, discusses some of the myths surrounding importation, and provides tips for saving money safely on the cost of prescription drugs.
The document discusses counterfeit medicine, including its definition, prevalence, consequences, evaluation, and methods to prevent it. It states that counterfeit medicine ranges from having no active ingredients to incorrect ingredients, and affects both developing and developed countries. Evaluation methods include using RFID, barcodes, Raman spectroscopy, and forensic analysis to identify counterfeits. Legislative authorities and improved regulation aim to curb the estimated $90 billion global counterfeit drug industry that causes over 1 million deaths annually.
1. Counterfeit drugs are a major global problem that negatively impact public health and pharmaceutical companies. They range from lacking active ingredients to having incorrect dosages and can lead to treatment failure, increased antimicrobial resistance, and even death.
2. India accounts for a large portion of the global counterfeit drug trade due to its large pharmaceutical industry, lack of regulation, and high drug prices. Many counterfeit drugs originate in India and are distributed worldwide.
3. Strategies to reduce counterfeiting include strengthening drug regulation, increasing inspections, consumer awareness campaigns, implementing track-and-trace technologies like barcodes and RFID in supply chains, and harsher penalties for counterfeiters.
The document discusses counterfeit medicines, which the WHO defines as deliberately mislabeled drugs regarding identity and/or source. Counterfeits can include both branded and generic drugs with incorrect ingredients, dosages, or packaging. Medicines are targeted due to lax regulations in some countries, price differences globally, and the complexity of distribution systems. Counterfeits pose health risks as they provide ineffective treatment and can spread drug-resistant diseases. Stronger enforcement is needed across governments, industries, and distribution networks to prioritize combating counterfeit drugs.
Securing the Global Pharmaceutical Supply Chain against the Threat of Counter...Yasmin AbdelAziz
In 2012, counterfeit versions of the cancer drug
Avastin were found in 19 American treatment
centers. The impostor drug lacked the active
ingredient, rendering it virtually useless for
treatment purposes.
I have been working on the topic of anti-counterfeiting for a number of years and find myself increasingly engrossed and thoroughly surprised as our understanding of this topic grows. The imagination and the brutality with which the criminal industry produces, distributes and sells imitation goods is unmatched. The consequences of such dire acts are not only killing children but also affecting the lives of many and fighting such forgery has become a personal battle for me.
This document discusses counterfeit medicines and measures to combat them. It defines counterfeit medicines according to WHO as those deliberately mislabeled regarding identity and/or source. The most common types of counterfeits are those without active ingredients or with incorrect quantities. Counterfeiting is prevalent in developing countries and online pharmacies. It poses dangers like treatment failure, toxicity, and drug resistance. Detection methods include chemical kits, barcodes, and Raman spectroscopy. Measures to combat counterfeits involve legislation, regulation, international cooperation, and awareness campaigns. Pharmacists play a role in preventing counterfeits from entering the supply chain.
In this webinar I provide an overview of counterfeits in America, I talk about some myths of importation, and I teach patients and patient advocates some great tips for saving money safely.
Online Access to Safe and Affordable Medication: Applying human rights law to...PharmacyChecker
Online Access to Safe and Affordable Medication: Applying human rights law to cyber rule-making and Internet governance
https://www.pharmacychecker.com/
Internet users are benefiting from online access to safe and affordable medications. The pharmaceutical industry views Internet access as a threat and disruptive to its profit model because consumers are paying less than the drug companies intended for them to pay. According to the UN Human Rights Council, access to affordable medication is a human right. As the Internet community seeks to infuse the principles of international human rights law into the discourse and practice of Internet governance it should help maintain the widest possible online access to safe and affordable medication.
https://www.pharmacychecker.com/
This document discusses the importance of proper labeling and promotion of drugs, as well as the various legal risks associated with mislabeling or improper promotion. It notes that manufacturers have the most information about drugs from clinical trials and post-market reports. The document defines what constitutes a drug label and outlines labeling requirements for both prescription and over-the-counter drugs. It also discusses standards and regulations from the FDA, FTC, and tort law regarding labeling as well as restrictions and exceptions for drug advertising and promotion.
This document discusses how cost considerations are driving the adoption of lean technologies in biosimilar manufacturing. Biosimilars face price pressure to compete with originator biologics, whose manufacturing processes are 10-15 years old. Newer technologies like single-use systems, perfusion bioreactors, and analytics like Biacore allow biosimilar manufacturers to develop smaller, more efficient continuous processes compared to legacy facilities. These lean technologies may help biosimilars achieve the cost competitiveness needed in the market.
This document summarizes the history of drug laws in the United States from the 1700s to present day. It discusses early regulation of alcohol and opium, the 1906 Pure Food and Drug Act, the Harrison Narcotic Act of 1914, prohibition, the Marihuana Tax Act of 1937, and major drug laws passed in the 1960s-2000s that aimed to increase drug safety regulations, control narcotics, and enforce harsher penalties for drug offenses. It also explores debates around decriminalization, legalization, harm reduction strategies, and the impacts of the war on drugs.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
This presentation is designed to train patient advocates in the safety issues around counterfeit drugs: how counterfeits enter our supply chain and how patients can protect themselves.
http://profitabletradingtips.com/trading-investing/trading-marijuana-stocks
Trading Marijuana Stocks
The state of Colorado has legalized marijuana for recreational use. Is there money to be made trading marijuana stocks? Technical analysis of these stocks may be difficult because of small trading volume. But, if other states adopt similar laws, trading marijuana stocks could be profitable to get in before stocks surge and get out before they level off. So, before we look at trading marijuana stocks let us look at the law in Colorado.
Colorado Law Regarding Marijuana Use
Colorado has two sets of laws regarding marijuana. These have to do with recreational use and medical use.
Colorado Amendment 64 says that:
adults aged twenty-one or older can grow up to three immature and three mature cannabis plants privately in a locked space, legally possess all cannabis from the plants they grow (as long as it stays where it was grown), legally possess up to one ounce of cannabis while traveling, and give as a gift up to one ounce to other citizens 21 years of age or older. Consumption is permitted in a manner similar to alcohol, with equivalent offenses proscribed for driving. Public consumption remains illegal. Amendment 64 also provides for licensing of cultivation facilities, product manufacturing facilities, testing facilities, and retail stores.
This law allows for sales of marijuana for recreational use, taxation of profits from these facilities, and various ordinances relating to such establishments. It is the potential for profit from recreational use of marijuana that is of primary interest in trading marijuana stocks.
Todays Marijuana And Its Effects on KidsSmartColorado
This document discusses the effects of legalized marijuana in Colorado, particularly on youth. It notes that while Amendment 64 legalized possession of small amounts of marijuana for adults 21+, commercialization of the drug has increased availability and lowered perceptions of risk among youth. Early and regular marijuana use can negatively impact adolescent brain development and is linked to higher risks of addiction, mental health issues, and lower IQ. The document expresses concerns about how the largely unregulated marijuana industry may be modeling practices after Big Tobacco to target and influence youth.
What Growers & Investors Need to Know: The cultivation laws in Oregon, Washington, Colorado and California are vastly different. Eric explains each states current cultivation laws and the reasons behind them. In addition to the best management practices for growing cannabis in a greenhouse environment for each states climate.
This document discusses medical marijuana. It provides background on marijuana and its classification. It assesses the efficacy and safety of medical marijuana for conditions like nausea, pain, appetite stimulation, and others. It also explains the legal implications of medical marijuana in the US and in states like Colorado and Illinois that have legalized it. Remaining challenges include a lack of standardized dosing and quality control. The pharmacist's role could include counseling patients, assessing drug interactions, and producing customized dosage forms.
Marijuana: The #1 Profit Opportunity for Greenhouse Growers in the Next DecadeGGS Structures Inc.
The document discusses the potential opportunities for greenhouse growers in the cannabis industry over the next decade. It notes that the legal cannabis market in the US and Canada is projected to be worth $44 billion by 2020. It provides an overview of the medical cannabis programs in Canada and regulations for licensed producers. The document also discusses factors for greenhouse growers to consider such as ventilation, lighting, irrigation and computer controls if pursuing cannabis cultivation. It emphasizes doing research and evaluating what skills align with long-term goals before deciding to enter the emerging industry.
Starting a Colorado Dispensary – Permits and Licenses You Should HaveDashThomas
To open a dispensary in Colorado, you will need several permits and licenses. Specifically, you need a medical marijuana vendor registration, seller's permit, Colorado medical marijuana business license, and either a key employee or support employee occupational license. You may also require a medical marijuana center business license, optional premises cultivation license, or infused product manufacturer license depending on the services offered. The Dispensary Experts website provides guidance on obtaining the necessary permits and licenses to legally operate a dispensary in Colorado.
The legal marijuana industry in Colorado has grown rapidly but faces challenges regarding water supply and compliance. Indoor cannabis cultivation requires different types of water rights than traditional irrigation. Federal restrictions ban using water from federal facilities for marijuana. States and localities have implemented solutions like allowing water leasing or requiring cultivation plans. While indoor use can be efficient, outdoor cultivation requires more water but systems vary significantly between operations.
Marijuana in Colorado - 10 Things You Need to KnowDashThomas
Colorado has some of the most progressive marijuana laws in the United States. The document outlines 10 things to know about marijuana laws in Colorado, including that residents can possess up to 1 ounce of marijuana and are allowed to gift marijuana to other adults. The laws also permit the cultivation of up to 6 marijuana plants per household and allow for the purchase of marijuana from licensed dispensaries for those over 21 years old, but prohibit smoking and driving or using marijuana in public spaces.
This webinar is focused on explaining the testing and analysis laws for marijuana in Colorado. Dr. Andy LaFrate, the President of Charas Scientific, goes over the testing law requirements and outlines what kind of testing is required, who must test and how often. This video is a great resource for anyone looking to learn about the new testing requirements that went into effect in Colorado's legal marijuana industry in 2014.
CannLabs presentation from WeedStock Investor Conference 2014CannLabs
CannLabs CEO, Genifer Murray and COO, Steve Kilts recently tag-teamed in a presentation at the Weedstock Conference hosted in Denver on June 30-July 1st, 2014. They discussed the current state of testing in the cannabis industry and their vision for the Company as the industry evolves. Their presentation was standing room only at this first annual event, and we wanted to share their presentation deck for those who were unable to attend.
Impact marijuana and Colorado commercialization - adult audiencesamcanada
The document outlines concerns about the effects of legalizing and commercializing marijuana in Colorado. It argues that Colorado should focus on marijuana prevention rather than promotion and that increased marijuana use does not benefit the state. The author believes that if legalization and commercialization continue unchecked, it could lead to the establishment of a new marijuana industry similar to big tobacco. The document promotes pursuing a "third way" or alternative approach that removes commercialization and returns to focusing on prevention and treatment of marijuana use.
This document summarizes emerging trends related to marijuana concentrates and edibles. It notes that Oregon legalized recreational marijuana use in 2014 and discusses popular concentrated forms like dabs, shatter, and BHO oil, which are extracted using dangerous home distilling methods. Edibles are noted to contain THC which is fat soluble and added to foods, with fatal incidents reported from overconsumption. Popular culture references to marijuana are increasing in music. Teen use data from local surveys shows gradual increases in reported use from 2010-2014. The document outlines strategies to prevent teen use through open communication and involvement between parents and children. It provides local resources for parents.
Legalization of Marijuana Webinar- Impact for Drug Testing Employers Eliassen Group
This document discusses the impact of legalizing marijuana and drug testing in the workplace. It notes that 23 states have legalized medical marijuana, creating challenges for employers maintaining drug-free workplaces. Ohio ballot issue 3 proposes legalizing medical and recreational marijuana use for those over 21. The document outlines employers' responsibilities regarding drug policies, noting they are not required to accommodate marijuana use given its federal illegality. It provides best practices for employers, such as maintaining consistent drug policies prohibiting impairment from any illegal substances.
Sugar beet cultivation under center pivot irrigation system.Dr. Mohamed Rady
The document describes the process of cultivating sugar beets using center pivot irrigation in Egypt. Key points include:
- Center pivot irrigation involves a circular irrigation system that rotates around a central pivot point, watering crops with sprinklers.
- The cultivation process for sugar beets under center pivot irrigation involves soil preparation, fertilizer application, sowing, weed control, and regular irrigation according to the crop's water needs at different growth stages.
- Factors like pivot calibration, nozzle selection, and an irrigation schedule help ensure proper water distribution and timing that optimizes sugar beet growth and yield.
Inspiring Minds - The Facts on Marijuana and Youth HealthSmartColorado
This document from Inspiring Minds discusses concerns about the impacts of legalized marijuana on youth in Colorado. It notes that today's marijuana is more potent than in the past, edible marijuana products are increasingly popular yet face few regulations, and accidental ingestions by children have increased. Data presented shows youth marijuana use rates in Colorado and Denver exceeding national averages since legalization. The organization is concerned about commercialization of the marijuana industry and increasing youth exposure and perception of harm.
This document provides a summary of a presentation on translating the science on marijuana into effective public health messages. The presentation aimed to understand the latest science on marijuana use and how to frame prevention messages. It identifies concerns related to marijuana use and legalization such as addiction, impaired driving, and negative impacts on adolescent brain development and academic achievement. The presentation argues for using strong evidence from research to change the discussion on marijuana from complicated to simple and from negative to positive. It provides sample messages focused on how marijuana use could negatively impact things people care about like education, employment, and highway safety.
This document discusses the history of drug regulation laws in the United States. It begins by covering early federal laws like the 1906 Pure Food and Drug Act that required labeling of drug contents but did little to regulate safety. The 1938 Food, Drug, and Cosmetic Act and later amendments in 1951 and 1962 strengthened regulations by requiring pre-market approval of drugs as safe and effective. The Controlled Substances Act of 1970 established a drug scheduling system to regulate substances based on abuse and medical potential. The document also discusses issues around legalization debates, prevention strategies, drug testing policies, and criticisms of discriminatory enforcement practices.
Alice P. Mead gave a presentation on the history of medical marijuana and the potential for developing marijuana-based medicines. She summarized that while crude marijuana extracts were used medically in the past, modern synthetic medicines replaced them. Identification of cannabinoids like THC in the 1960s renewed scientific interest. GW Pharmaceuticals is developing standardized pharmaceutical cannabinoid medicines and conducting international clinical trials through the FDA process to establish safety and efficacy. Developing marijuana as a modern medicine requires meeting standards for composition, dosage, and delivery unlike herbal "medical marijuana".
The FDA has a long history dating back to the early 19th century when organizations were established to set standards for drugs and food. Over time, in response to issues like unsafe drugs killing many Americans, the FDA was created through laws like the 1906 Pure Food and Drug Act. The FDA now regulates food, drugs, medical devices, cosmetics and more to protect public health. It ensures products are safe and properly labeled through inspections and enforcement of cGMP regulations. The FDA works with other domestic and international groups to harmonize standards globally.
Cannabis/Marijuana Report Recommendations Would Delay Legalization To 2018 Or...paul young cpa, cga
This presentation looks at the issues facing cannabis/pot/marijuana legalisation in Canada. There are many issues driving legalisation including policing, UN rules, United States Policies, enforcement, side-effects, etc.
The document discusses the history of drug regulation laws in the United States from the early 1900s to present day. It covers major acts and amendments that aimed to regulate drugs and drug development, including the 1906 Pure Food and Drug Act, Harrison Act of 1914, 1970 Controlled Substances Act, and Kefauver-Harris Amendments. The "War on Drugs" of the 1980s is also summarized, which took a criminal justice approach to drug abuse. Prevention strategies discussed include supply reduction, demand reduction, and harm reduction approaches.
This document provides an overview of regulatory affairs and its importance in the pharmaceutical industry. It discusses how regulatory affairs developed due to governments' desire to control medicine safety and efficacy. The regulatory affairs professional ensures products comply with all regulations. The document outlines some key drug regulation events that prompted stricter laws, such as the 1901 diphtheria antitoxin contamination and the 1960 thalidomide tragedy. It also summarizes the role of regulatory authorities like the FDA and regulatory affairs departments in obtaining marketing authorization and maintaining compliance.
Government policies for Marijuana (Pot) - Canada - Analysis and Commentary - ...paul young cpa, cga
This presentation will look at medical marijuana as well as the government of Canada goal to legalised marijuana (Pot) in Canada. The discussion will look at areas like revenue, healthcare, enforcement, regulations, etc.
This document provides an overview and update on substance use patterns and addiction treatment. Recent trends show declines in substance use among teenagers but increases among young adults for some substances like cannabis. Relapse is addressed as a chronic condition requiring continuity of care. Specific substances discussed include tobacco/e-cigarettes, cannabis, opioids, and benzodiazepines. Ongoing issues like diversion of medications and integrating addiction treatment into the community are also covered.
June 19, 2013: This presentation to highlight the dangers of counterfeit drugs to Maine patients was given to the Bangor Dept. of Health Public Advisory committee
Drug use and regulation have occurred since colonial times, with early focus on alcohol and opium. Over time, laws targeted specific drugs like cocaine and marijuana, and established agencies like the FDA and DEA. Debate continues over whether drug laws deter use and whether alternative approaches could better balance public health and civil liberties. Enforcement efforts face challenges in stemming the flow of illegal drugs.
Drug use and regulation have occurred since colonial times, with early focus on alcohol and opium. Over time, laws targeted specific drugs like cocaine and marijuana, and established agencies like the FDA and DEA. Debate continues over whether drug laws deter use and whether alternative approaches could better balance public health and civil liberties. Enforcement efforts face challenges in stemming the flow of illegal drugs.
This document discusses the complex issues surrounding the legalization of cannabis in the United States. It notes that while some states have legalized cannabis for medical or recreational use, possession and distribution remain illegal under federal law. It outlines many open questions and complexities regarding the botany, chemistry, and effects of cannabis, as well as considerations for public health, patient and consumer protection, labeling requirements, and the future of the cannabis industry. The document argues that as public acceptance of cannabis legalization grows, there is a need for more research and a high time to legalize and regulate cannabis at the federal level.
This document summarizes a presentation on the emerging issues related to legalized marijuana. It discusses how marijuana legalization is impacting various areas of law and insurance claims. Legalized marijuana directly impacts professional liability, transportation, employment, premises liability and other areas. While public opinion and usage is increasing, federal law still prohibits marijuana use. States are passing legislation to legalize medical and recreational marijuana use, creating conflicts with federal law. This is generating new types of lawsuits and insurance claims around issues like indemnity agreements and additional insured coverage. Presenters discussed open questions around how these legal and regulatory changes will further impact claims handling and different professions.
Government policies for Legalizing Marijuana - Canada - Analysis and Commentarypaul young cpa, cga
This presentation discusses the effort by the Government of Canada to legalised Pot/Marijuana in Canada.
The presentation will look at all aspects of legalising marijuana including costs associated to the program as well as the revenue that could be generated from pot/marijuana sales.
The document discusses Canada's plans to legalize marijuana. It outlines the agenda, including definitions of marijuana, potential short-term and long-term health effects, the UN's stance on drug enforcement worldwide, and the costs associated with implementing legalization. The author estimates the potential market size in Canada could be $5-8.7 billion annually and outlines leading marijuana companies like Canopy Growth Corp. The document concludes that marijuana should be legalized but the government must fully fund associated health, legal and regulatory costs and work with other countries to change international drug laws.
This summary provides an overview of the key points from the document:
- The document discusses a work that is licensed under a Creative Commons license. It states that use of materials from the site constitutes acceptance of the license terms and conditions.
- Copyright is held by Johns Hopkins University and Thomas Layloff for the materials, and all rights are reserved. Materials are provided "as is" and no representations or warranties are provided. Users are responsible for ensuring accuracy.
- The document is a session on drug manufacture, industrial pharmacy considerations, quality assurance, and regulation. It covers topics like GMP, requirements for domestic manufacturing, brand vs generic drugs, and procedures to prevent counterfeiting.
The legalization of cannabis was a key election promise in 2015. Cannabis has been legalized but there have been many issues with cannabis over the past two years.
Where the Money Grows: Learning the Industry Trends in Medical Cannabis, Recr...Aggregage
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Join international cannabis and securities business attorney Jonathan Bench as he provides some pitfalls and best practices for companies & individuals looking to engage with the U.S. cannabis marketplace.
Similar to Agroterrorism and Agro Crime to United States Cannabis Industry (20)
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
2. Overview
• New industry
• Conflict of law
• Many forms
• Agrocrime
• Agroterrorism
• Plant Disease
• California
• Colorado
• Connecticut
• Unscheduled Drug
• Federal Oversight
• Top-down
Approach
• Will it work?
• Other
Solutions
• Questions
ProblemsBackground Case Studies Solutions Discussion
3. Market Background
• Newest “official” agriculture market. By 2016, will reach
$9B
• In the 1980s, it was estimated the domestic production
was $32B. In 2000s, 36B, 50% greater than corn, the
next largest cash crop
• Since 2006, 20 states and DC have passed laws
allowing smoked marijuana to be used medicinally
• Not just medical and recreational use: Hemp
4. Legal Background
• The State of California under proposition 215 and SB
420 allows “medical” marijuana and home grow
• Notoriously easy to obtain ID card, essentially legalizing
recreational marijuana
• In conflict, Federal Government asserts that marijuana is
not a medicine and SCOTUS held that federal
government can restrict marijuana unconditionally
• Harsh criminal prosecution and fines
5. Implications of Law on Cannabis
Agriculture
• Declared as Schedule I Drug, No federal funds can be
used to develop robust systems
• No ARS, APHIS, FDA, USDA
• This creates a “free-for-all”, leaving regulation to the
states
• Unique position not seen in any other ag. sector
• Allows extreme flexibility at the state level, but is this
good or bad?
6. Threats: Agrocrime
• Adulteration: “bulk up” weight to increase
selling price. Use lead or beads.
• NEJM Leipzig Germany lead poisoning in
29 patients from adulterated black market
marijuana
• Salmonellosis: NEJM cites multi-state
(Massachusetts to California) outbreak in
early 1980s, 85 cases
• Questions: how often does adulteration
occur? Accidental or purposeful? At what
point in production did adulteration
occur?
7. Threats: Agroterrorism
• In 2011, the entire 400 million base-pair genomic
sequence of Cannabis Sativa was published online
• Allows continued research to the medicinal effects of
Tetrahydrocannabinol and Cannabanoids
• Could place THC production in anything
• Could create mutant strain
• Similar to H7N9 controversy
8. Threats: Plant Disease
• For commercial Ag. Sector, strict guidelines govern the use of
pesticides, no such legislation exists for the cannabis industry
• Little research on pesticides and the cannabis plant,
especially a substance that is smoked and not eaten
• Fungi: 88 species affect cannabis: Gray Mold and Hemp
Canker, leaf spot
• Nematodes: roundworm
• Parasitic Plants
• Viruses: Hemp Streak Virus
• Bacteria: Bacterial Blight
• Plagues and Pests: Lice, Wasps, Flies
10. Case Study: California
• California Proposition 215; enacted, on November 5, 1996
• established MMJ program, allowed cultivation of marijuana
• established collective and cooperative distribution
– qualified patients and caregivers may possess 8 ounces of
dried marijuana
– maintain 6 mature or 12 immature marijuana plants
– local governments may allow patients or caregivers to
exceed these levels
11. Case Study: California
• California Senate Bill 420
– clarified Prop 215
• "require[s] the Attorney General to develop and adopt
guidelines to ensure the security and nondiversion of
marijuana grown for medical use"
• allows counties to increase plant number
12. Implications in California
• relatively liberal use of marijuana as implemented
• no mention of agro safety or defense
– high risk of contamination, agrocrime
– No testing requirements
• Permits establishment of collectives
– Collectives purchase from members
– No tracking of plants of “seed to sale”
• “Wild west of weed”
13. Case Study: Colorado
• Colorado Department of Revenue, Marijuana Enforcement
Division, 1 CCR 212-2 Very strict guidelines on the retail,
licensing, cultivation, facility requirements
• Facility Guidelines:
– Established limited access area with credentialing to
visitors, ID Check, Visitor Log
– Building plans must be approved by state
– Separates medical and recreational marijuana
– Surveillance and alarm system requirements with
redundancy
• Direct positioning of cameras
– Physical security, locks, fences
14. Case Study: Colorado
• Inventory Tracking
– MITS
– May only sell product from licensed manufacture
• Testing
– Business must provide samples for testing
• Personnel
– No consumption on the premises
15. Case Study: Colorado
Must be stored away from chemicals
Packaging and labeling standards
Must test samples for:
• Mold, mildew, filth
• Microbial
• Herbicides, pesticides, fungicides
• Harmful chemicals
• Solvents, poisons, toxins
Testing labs are separate and have own regulations
• Outlines exact testing procedure
• Educational requirements of lab director and
technicians
17. Colorado Legislation Analysis
• Strengths:
– Very tightly controlled
– Prevents gray and black market product from entering
legitimate market
– Ensures marijuana is free of contaminants at the point of
testing
• Weaknesses: (Production, Distribution, Retail)
– Potential for insider threat still exists
• No regulation on training and vetting of dispensary staff
• Creation of higher demand in illegal market due to high
operating cost, Purchase limit counterproductive
– “gray market” of caregiving growing, becoming
illegal commercial operations
18. Program Audit
Feb 2013 audit in Colorado found: Budgets kept MITS from
working fully
• Do we need “micro-level” control since growing rec
cannabis is allowed under amendment 64?
• 40% of business applications have not be vetted or
approved
• 13 of 35 applications that were approved contained
“potentially disqualifying information”
• licenses issued prior to results of criminal background
check
– Past arrest, felony robbery and menacing with a
deadly weapon
19. Discussion
• Clearly, Colorado is better shape than California
• California is highly susceptible to contaminated crop
• This will be consistent theme under current Federal Regs.
20. Solution
The only way to ensure safe and protected product is using a
“top-down” approach
– Must be removed from Schedule I list
– Must be regulated like alcohol (w/ personal cultivation
limits, selling restrictions)
• Alcohol model works
• FDA and USDA oversight
• Will ensure legislation is consistent and effective
– Categorizing it as a “Drug Store” drug won’t be effective
Look beyond the US, Uruguay Federal Crop, DNA Tracked
21. Solution
• Not all bad
– Clean Green Certified in California: Organic certification
– Emerging reactive legislation about personnel in Colorado
• Legislation that is put into place must be followed through on,
a federal specialty, checks and balances
22. References
Busse, F., Omidi, L., Leichtle, A., Windgassen, M., Kluge, E., & Stumvoll, M. (2008). Lead poisoning
due to adulterated marijuana. N Engl J Med, 358(15), 1641-1642. doi:10.1056/NEJMc0707784
Chaboya-Hembree, J. (2012). Diseases of cannabis. Retrieved March 23, 2014, from
http://medicalmarijuana.com/experts/expert/title.cfm?artID=727
DRAFT permanent rules related to the Colorado retail marijuana code, R 100 (2013).
Decorte, T., Potter, G. W., & Bouchard, M. (2011). World wide weed: Global trends in cannabis
cultivation and its control Ashgate Publishing, Ltd.
Gorski, E. (2013, ). Audit: Serious flaws in Colorado's regulation of medical marijuana. Denver
Post
Office of National Drug Control Policy. (2013). Marijuana resource center: State laws related to
marijuana. Retrieved March 23, 2014, from http://www.whitehouse.gov/ondcp/state-laws-related-to-
marijuana
Compassionate use act of 1996, (1996).
Russo MD, E. (2012). Cannabis genome uncloaked. Retrieved March 23, 2014, from
http://www.icrs.co/content/Cannabis_Genome_Uncloaked.pdf
Small, E., & Marcus, D. (2002). Hemp: A new crop with new uses for north america. Trends in New
Crops and New Uses, , 284-326.
California senate bill 420 "Medical marijuana program act", 11362.7 (2003).
Editor's Notes
Potential to reach levels of tobacco and alcohol, perhaps more?
Hemp: Hemp was first cash crop grown in the colonies
Used extensively as rope and paper
Textiles, food, building supplies, fuel
Used to clarify soil at Chernobyl
That being said, agroterrorism is unlikely at this point, maybe once population relies more on the crop
That being said, agroterrorism is unlikely at this point, maybe once population relies more on the crop
Explain Collectives
Paid 1.1 million but could close with aoth 400k
Voters have already decided it should be used recreationally
Will create inconsistent market
Have to go to CVS in DC, but buy at 7-11 in Colorado
How could we regulate this?
Some updates in the last two weeks:
Attorney General Eric Holder states he would be willing with the Obama to reschedule Cannabis
Legislation introduced in CO to improve personnel reliability